PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO

42/2000
15256 PCT Gazette - Section I - Gazette du PCT 19 Oct/oct 2000
CLAIRANCE DES PEPTIDES NATRIU-
RETIQUES AURICULAIRES
(71) ASTRAZENECA AB [SE/SE]; S–151 85
Södertälje (SE).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) VEALE, Chris, Allan [US/US]; 1800
Concord Pike, Wilmington, DE 19850–5437
(US). EDWARDS, Philip, Duke [US/US];
1800 Concord Pike, Wilmington, DE
19850–5437 (US). JACOBS, Robert, Toms
[US/US]; 1800 Concord Pike, Wilmington,
DE 19850–5437 (US). DAVENPORT,
Timothy, Wayne [US/US]; 1800 Concord
Pike, Wilmington, DE 19850–5437 (US).
WARWICK, Paul, James [US/US]; 1800
Concord Pike, Wilmington, DE 19850–5437
(US).
(74) PHILLIPS, Neil, Godfrey, Alasdair; Astrazeneca,
Global Intellectual Property, P.O.
Box 272, Mereside, Alderley Park, Macclesfield,
Cheshire SK10 4GR (GB).
(81) JP US; EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE).
(51) 7 C07K 14/705, 14/47, A61P 37/02
(11) WO 00/61632 (13) A1
(21) PCT/US00/09647
(22) 12 Apr/avr 2000 (12.04.2000)
(25) en (26) en
(30) 09/291,152 12 Apr/avr 1999
(12.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
US
(54) INTERACTION OF MHC CLASS II
PROTEINS WITH MEMBERS OF THE
PCNA FAMILY OF PROTEINS
INTERACTION DE PROTEINES MHC
DE CLASSE II AVEC LA FAMILLE DE
PROTEINES PCNA
(71) STANFORD UNIVERSITY [US/US]; Office
of Technology Licensing, Suite 350, 900
Welch Road, Palo Alto, CA 94304–1805
(US).
(72) CLAYBERGER, Carol, A.; 812 Mayfield
Avenue, Stanford, CA 94305 (US).
KRENSKY, Alan, M.; 812 Mayfield Avenue,
Stanford, CA 94305 (US).
(74) MAYS, Thomas, D. et al. / etc.; Morrison
& Foerster LLP, 2000 Pennsylvania Avenue,
N.W., Washington, DC 20006–1888 (US).
(81) AU CA JP; EP (AT BE CH CY DE DK ES
FI FR GB GR IE IT LU MC NL PT SE).
Published / Publiée :(c)
(51) 7 C07K 14/745, 1/14, A61K 38/37
(11) WO 00/61633 (13) A1
(21) PCT/JP00/02350
(22) 11 Apr/avr 2000 (11.04.2000)
(25) ja (26) ja
(30) 11/104587 12 Apr/avr 1999
(12.04.1999)
JP
(43) 19 Oct/oct 2000 (19.10.2000)
(54) METHOD FOR PURIFYING BLOOD
COAGULATION FACTOR VIII AND
BLOOD COAGULATION FACTOR
VIII/VON WILLEBRAND FACTOR
COMPLEX
PROCEDE DE PURIFICATION DU
FACTEUR VIII DE COAGULATION
SANGUINE ET DU COMPLEXE DE
FACTEUR VIII DE COAGULATION
SANGUINE ET DE FACTEUR VON
WILLEBRAND
(71) FUJIMORI KOGYO CO., LTD. [JP/JP];
4–16, Nihonbashibakurocho 1–chome,
Chuo–ku, Tokyo 103–0002 (JP).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) HOSOKAWA, Kazuya [JP/JP];
1547–1, Kamimarukosannoucho, Nakahara–ku,
Kawasaki–shi, Kanagawa
211–0002 (JP). SUZUKI, Toyoaki [JP/JP];
4–2–24, Nishiichinoe, Edogawa–ku, Tokyo
132–0023 (JP). NAGATA, Masanori
[JP/JP]; 3–16–40, Nishiohi, Shinagawa–ku,
Tokyo 140–0015 (JP).
(74) HATTA, Mikio et al. / etc.; Dia Palace Nibancho,
11–9, Nibancho, Chiyoda–ku, Tokyo
102–0084 (JP).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY CA CH CN CR CU CZ DE DK DM DZ
EE ES FI GB GD GE GH GM HR HU ID
IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW
MX NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG US UZ
VN YU ZA ZW; AP (GH GM KE LS MW
SD SL SZ TZ UG ZW); EA (AM AZ BY
KG KZ MD RU TJ TM); EP (AT BE CH
CY DE DK ES FI FR GB GR IE IT LU MC
NL PT SE); OA (BF BJ CF CG CI CM GA
GN GW ML MR NE SN TD TG).
(51) 7 C07K 14/81, G01N 33/68, C12N 15/31
(11) WO 00/61634
(21) PCT/US00/09790
(13) A2
(22) 12 Apr/avr 2000 (12.04.2000)
(25) en (26) en
(30) 09/290,513 12 Apr/avr 1999
(12.04.1999)
US
(43) 19 Oct/oct 2000 (19.10.2000)
(54) ENGINEERING ECOTIN–VARIANT
MODULATORS OF SERINE PRO-
TEASES
MODULATEURS VARIANTS DE
L’ECOTINE DE GENIE GENETIQUE
AGISSANT SUR DES SERINES PRO-
TEASES
(71) THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA [US/US]; 1111 Franklin
Street, 12th floor, Oakland, CA 94607–5200
(US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) CRAIK, Charles, S. [US/US]; 520 Oak
Park Drive, San Francisco, CA 94131 (US).
FLETTERICK, Robert, J. [US/US]; 15
Christopher Drive, San Francisco, CA 94131
(US).
(74) HUNTER, Tom et al. / etc.; Majestic,
Parsons, Siebert & Hsue P.C., Four Embarcadero
Center, Suite 1100, San Francisco, CA
94111–4106 (US).
(81) AE AL AM AT AU AZ BA BB BG BR BY
CA CH CN CR CU CZ DE DK DM EE ES
FI GB GD GE GH GM HR HU ID IL IN
IS JP KE KG KP KR KZ LC LK LR LS LT
LU LV MA MD MG MK MN MW MX NO
NZ PL PT RO RU SD SE SG SI SK SL TJ
TM TR TT TZ UA UG US UZ VN YU ZA
ZW; AP (GH GM KE LS MW SD SL SZ
TZ UG ZW); EA (AM AZ BY KG KZ MD
RU TJ TM); EP (AT BE CH CY DE DK ES
FI FR GB GR IE IT LU MC NL PT SE);
OA (BF BJ CF CG CI CM GA GN GW ML
MR NE SN TD TG).
(51) 7 C07K 16/00, 16/18, 16/46, A61K 39/395,
C12N 15/13
(11) WO 00/61635 (13) A2
(21) PCT/EP00/03176
(22) 10 Apr/avr 2000 (10.04.2000)
(25) en (26) en
(30) 99 10 7030.1 9 Apr/avr 1999
(09.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
EP
(54) METHOD FOR THE STABILIZATION
OF CHIMERIC IMMUNOGLOBULINS
OR IMMUNOGLOBULIN FRAG-
MENTS, AND STABILIZED ANTI–
EGP–2 SCFV FRAGMENT
PROCEDE DE STABILISATION
D’IMMUNOGLOBULINES CHI-
MERES OU DE FRAGMENTS
D’IMMUNOGLOBULINE CHIMERE,
ET FRAGMENT DE SCFV ANTI–EGP–
2 STABILISE
(71) UNIVERSITÄT ZÜRICH [CH/CH];
Rämistrasse 71, CH–8006 Zürich (CH).
(for all designated States except / pour tous
les États désignés sauf US)
(71, 72) PLÜCKTHUN, Andreas [DE/CH];
Möhrlistrasse 97, CH–8006 Zürich (CH).
(72, 75) HONEGGER, Annemarie [CH/CH];
Murwiesenstrasse 32, CH–8057 Zürich
(CH). WILLUDA, Jörg [DE/DE]; Uhlandstrasse
66, D–13156 Berlin (DE).
(74) VOSSIUS & PARTNER; P.O. Box 86 07
67, D–81634 Munich (DE).
(81) CA JP US; EP (AT BE CH CY DE DK ES
FI FR GB GR IE IT LU MC NL PT SE).
(51) 7 C07K 16/00
(11) WO 00/61636 (13) A2
(21) PCT/US00/09907
(22) 14 Apr/avr 2000 (14.04.2000)
(25) en (26) en
(30) 60/129,163 14 Apr/avr 1999
(14.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
US